These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 22280056)

  • 1. Pharmacokinetics and pharmacodynamics of pegylated interferon lambda-1 in cynomolgus monkeys.
    Byrnes-Blake KA; Pederson S; Klucher KM; Anderson-Haley M; Miller DM; Lopez-Talavera JC; Freeman JA
    J Interferon Cytokine Res; 2012 May; 32(5):198-206. PubMed ID: 22280056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pegylated interferons Lambda-1a and alfa-2a display different gene induction and cytokine and chemokine release profiles in whole blood, human hepatocytes and peripheral blood mononuclear cells.
    Freeman J; Baglino S; Friborg J; Kraft Z; Gray T; Hill M; McPhee F; Hillson J; Lopez-Talavera JC; Wind-Rotolo M
    J Viral Hepat; 2014 Jun; 21(6):e1-9. PubMed ID: 24827902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical and clinical development of pegylated interferon-lambda 1 in chronic hepatitis C.
    Ramos EL
    J Interferon Cytokine Res; 2010 Aug; 30(8):591-5. PubMed ID: 20645873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
    Liu B; Chen S; Guan Y; Chen L
    PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline sensitivity of T cells to alpha-IFN correlates with sustained virological response to IFN-based triple therapy in HCV infection.
    Sultanik PS; Casrouge A; Alanio C; Mottez E; Rosa-Hézode I; Hézode C; Renard P; Bousquet L; Pellet P; Uzé G; Pol S; Albert ML; Mallet V
    J Viral Hepat; 2015 Jun; 22(6):524-34. PubMed ID: 25382001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections.
    Wang W; Yin Y; Xu L; Su J; Huang F; Wang Y; Boor PPC; Chen K; Wang W; Cao W; Zhou X; Liu P; van der Laan LJW; Kwekkeboom J; Peppelenbosch MP; Pan Q
    Sci Signal; 2017 Apr; 10(476):. PubMed ID: 28442624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-lambda (IFN-λ) induces signal transduction and gene expression in human hepatocytes, but not in lymphocytes or monocytes.
    Dickensheets H; Sheikh F; Park O; Gao B; Donnelly RP
    J Leukoc Biol; 2013 Mar; 93(3):377-85. PubMed ID: 23258595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of response to exogenous interferon-alpha in the liver of chimpanzees chronically infected with hepatitis C virus.
    Lanford RE; Guerra B; Bigger CB; Lee H; Chavez D; Brasky KM
    Hepatology; 2007 Oct; 46(4):999-1008. PubMed ID: 17668868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of interferon-stimulated genes is strongly associated with therapeutic outcomes in hepatitis B virus infection.
    Han M; Li Y; Wu W; Zhang Y; Yan W; Luo X; Ning Q
    Antiviral Res; 2017 Nov; 147():75-85. PubMed ID: 28988797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients.
    Murakawa M; Asahina Y; Kawai-Kitahata F; Nakagawa M; Nitta S; Otani S; Nagata H; Kaneko S; Asano Y; Tsunoda T; Miyoshi M; Itsui Y; Azuma S; Kakinuma S; Tanaka Y; Iijima S; Tsuchiya K; Izumi N; Tohda S; Watanabe M
    J Med Virol; 2017 Jul; 89(7):1241-1247. PubMed ID: 28036111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-Mediated Cytokine Induction Determines Sustained Virus Control in Chronic Hepatitis C Virus Infection.
    Wandrer F; Falk CS; John K; Skawran B; Manns MP; Schulze-Osthoff K; Bantel H
    J Infect Dis; 2016 Mar; 213(5):746-54. PubMed ID: 26503984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment induced clearance of hepatitis E viruses by interferon-lambda in liver-humanized mice.
    Sari G; Mulders CE; Zhu J; van Oord GW; Feng Z; Kreeft-Voermans JJC; Boonstra A; Vanwolleghem T
    Liver Int; 2021 Dec; 41(12):2866-2873. PubMed ID: 34392598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Cell Profiling of IFN-λ Response Shows pDCs Express Highest Level of IFN-λR1 and Are Directly Responsive via the JAK-STAT Pathway.
    Kelly A; Robinson MW; Roche G; Biron CA; O'Farrelly C; Ryan EJ
    J Interferon Cytokine Res; 2016 Dec; 36(12):671-680. PubMed ID: 27617757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-free treatment for hepatitis C virus infection induces normalization of extrahepatic type I interferon signaling.
    Sung PS; Lee EB; Park DJ; Lozada A; Jang JW; Bae SH; Choi JY; Yoon SK
    Clin Mol Hepatol; 2018 Sep; 24(3):302-310. PubMed ID: 29526079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I interferon signaling in systemic immune cells from patients with alcoholic cirrhosis and its association with outcome.
    Weiss E; Rautou PE; Fasseu M; Giabicani M; de Chambrun M; Wan J; Minsart C; Gustot T; Couvineau A; Maiwall R; Hurtado-Nedelec M; Pilard N; Lebrec D; Valla D; Durand F; de la Grange P; Monteiro RC; Paugam-Burtz C; Lotersztajn S; Moreau R
    J Hepatol; 2017 May; 66(5):930-941. PubMed ID: 28040548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between human TRIM22 gene expression and the response to combination therapy with Peg-IFNα-2a and ribavirin in Iranian patients with chronic hepatitis C.
    Sadeghi F; Bokharaei-Salim F; Salehi-Vaziri M; Monavari SH; Alavian SM; Salimi S; Vahabpour R; Keyvani H
    J Med Virol; 2014 Sep; 86(9):1499-506. PubMed ID: 24889558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
    Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
    Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of interferon alpha-2b and pegylated interferon alpha-2b on menstrual cycles and ovarian hormones in cynomolgus monkeys.
    Enright BP; Compton DR; Collins N; Davis T; McIntyre BS
    Birth Defects Res B Dev Reprod Toxicol; 2009 Feb; 86(1):29-39. PubMed ID: 19243028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms for regulation of cellular responsiveness to human IFN-beta1a.
    Dupont SA; Goelz S; Goyal J; Green M
    J Interferon Cytokine Res; 2002 Apr; 22(4):491-501. PubMed ID: 12034032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus.
    Feng X; Chen W; Xiao L; Gu F; Huang J; Tsao BP; Sun L
    Lupus; 2017 Jan; 26(1):62-72. PubMed ID: 27230555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.